Skip to content
Unrated Drug recall · FDA · Published July 26, 2016

Vital Care Compounder Hyaluronidase Recall: Lack of Sterility Assurance

Pharmacy Plus, Inc. dba Vital Care Compound: Hyaluronidase 150 u/ml 10ml SDV with lot #398178 (use by 12/30/16) recalled due to lack of sterility assurance.

🇺🇸 FDA recall #D-1548-2016DrugVital Care Compounder ›
Take action

Contact the company

Recalling firmPharmacy Plus, Inc. dba Vital Care Compounder115 S 40th Ave · Hattiesburg, MS 39402-6600
✎ GovInfoNow plain-language explainer

What happened, in plain English

Vital Care Compounder is recalling Hyaluronidase 150 u/ml, 10 ml SDV products from lot #398178 (use by 12/30/16) because they may not be sterile. This could lead to infections if used improperly. Read more at govinfonow.com/recall/42517-vital-care-compounder-hyaluronidase-recall-lack-of-sterility-assurance.

Source Summary by GovInfoNow · govinfonow.com/recall/42517-vital-care-compounder-hyaluronidase-recall-lack-of-sterility-assurance · Updated October 9, 2026 · FDA enforcement record: FDA #D-1548-2016

Cite this page

“Vital Care Compounder Hyaluronidase Recall: Lack of Sterility Assurance.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42517-vital-care-compounder-hyaluronidase-recall-lack-of-sterility-assurance. Based on FDA recall #D-1548-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1548-2016%22&limit=1).

Why it’s dangerous

The product may not be sterile, which can cause infections if injected. This is a serious risk for medical use where contamination could lead to health complications.

Who’s affected

Healthcare professionals and patients using this specific lot of Hyaluronidase for medical purposes are affected. Those with the product from the specified lot and use date are at risk.

How to tell if you have this one

Check for the lot number 398178 on the product label. The product was sold with a use-by date of December 30, 2016.

  • Brand
    Vital Care Compounder
  • Category
    Drug
FDA recall event · 21 products

All 21 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    MS
Recall numberProduct, codes & lotsQuantity
D-1529-2016Chlorpheniramine Maleate 10 mg/ml, 30 ml MDV, Rx, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 373003, 381408, Use by 02-11-17108 vials
D-1530-2016Buprenorphine, 0.6 mg/ml Injection, 20ml MDV Sterile, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 396691, Use by 09-13-165 vials
D-1531-2016Apomorphine HCl 3mg/ml Sterile Injection Solution, 10 mL, MDV, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 397876, Use by 10-27-161 vial
D-1532-2016Moxifloxacin 0.5% + Dexamethazone 0.1%, 15ml vial Contains: Moxifloxacin 5mg/ml, Dexamethasone Sodium Phosphate 1mg/ml, Rx only, For ophthalmic use only, Vital Care Compounder, Hattiesburg, MS; Lot# 396627, Use by 8-10-161 vial
D-1533-2016MOXI/DEX/KETOROLAC 0.5%/0.1%/0.4%, #15, Vital Care Compounder, Hattiesburg, MS 39402; Lot#: 399080, Use by 8-14-16; 399740, Use by 8-25-16; 398952, Use by 8-13-16; 398865, Use by 8-11-16; 399057, Use by 8-13-16; 398864, Use by 8-11-166 vials
D-1534-2016Papaverine 150 mg / Phentolamine 5 mg vials, packaged 5.5 mL in a sterile, clear 10 mL MDV, Rx only, Sterile Injection, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 386184, Use by 08-03-163 vials
D-1535-2016Papaverine 150 mg/Phentolamine 5 mg and Prostaglandin 50 mcg, packaged as 5.5 mL in a 10 mL MDV, Rx only, Vital Care Compounder, Hattiesburg, MS 39402; Lot#: 386606, Use by 8-9-16, 393302, Use by 10-28-16386606 - 3 vials, 393302 - 3 vials
D-1536-2016Trypan Blue 0.3%, 0.5ml vials, Rx, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 396770, Use by 09-13-1662 vials
D-1537-2016Brilliant Blue G (BBG) 0.025%, 0.5 ml SDV, Rx, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 396817, Use by 09/13/1614 vials
D-1538-2016Moxifloxacin HCl 1 mg/ml (0.1mg/0.1ml) and BSS solution, 2ml Single use vial, Rx, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 396607, Use by 08/13/1616 vials
D-1539-2016Morphine Sulfate 15mg/ml Injection, 20 ml MDV, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 396689, Use by 12-13-161 vial
D-1540-2016Methylcobalamin 5,000mcg/ml, 1mL SDV, Rx, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 396814, Use by 12-14-1636 vials
D-1541-2016Autologous Serum Tears, 2 vials, Rx, Vital Care Compounder, Hattiesburg, MS 39402; Lot#: 390325, Use by 08/01/16; 382789, Use by 08/07/16; 396766, Use by 08/11/16; 393470, Use by 08/14/16; 393036, Use by 08/14/16; 398131, Use by 08/15/16; 389288, Use by 08/20/16; 392969, Use by 08/21/168 bottles
D-1542-2016Pre-Op Pledget Soln, Ophthalmic Drops (Tropicamide (1%) 0.33ml, Phenylephrine (10%) 0.66ml, Ketorolac (0.5%) 0.33ml, Ofloxacin (0.3) 0.67ml, 2ml vial, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 397267, Use by 9/20/166 vials
D-1543-2016Pre-Op Pledget Soln + Tetracaine, (Tropicamide (1%) 0.47ml, Phenylephrine (10%) 0.93ml, Ketorolac (0.5%) 0.47l, Ofloxacin (0.3) 0.95, Tetracaine (0.5%), 3ml vial, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 397269, Use be 9/20/166 vials
D-1544-2016Hydroxyzine HCl, 50mg/ml Inj, 10ml MDV, Rx, Vital Care Compounder, Hattiesburg, MS; Lot #: 365204, Use by 8/1/16 and 384395, Use by 3/12/17139 vials
D-1545-2016C-PAP/PHEN/PROST/ATROP 150/5/5 (Papaverine 150mg/Phentolamine 5mg/Prostaglandin 50mcg/Atropine 0.04mg injection), Rx, 10 ml vials contain 5.8 ml solution, Vital Care COMPOUNDER, Hattiesburg, MS 39402; Lot# 397877, USE BY 1-6-171 vial
D-1546-2016Olopatadine 0.8% Ophthalmic Solution, 3ml bottle, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 389278, Use by 8-9-16N/A
D-1547-2016C-PAP/PHEN/PROST/Atrop 150/7.5 (Papaverine 150mg/Phentolamine 7.5mg/Prostaglandin 75mcg/Atropine 1mg injection), 10 ml vial containing 5.9ml solution, Rx, Vital Care Compounder, Hattiesburg, MS; Lot# 397877, USE BY 1-6-171vial
D-1548-2016Hyaluronidase, 150 u/ml, 10 ml SDV, Vital Care Compounder, Hattiesburg, MS 39402; Lot# 398178, Use by 12/30/1623 vials
D-1549-2016DMSO 50% with Lidocaine 0.5%, 50ml SDV, Sterile, Rx, Vital Care Compounder, Hattiesburg, MS; Lot # 389321, Use by 3/10/176 vials
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot number 398178 on the Hyaluronidase 150 u/ml, 10 ml SDV product.

Where it went and when

Where it was distributed

Distributed in Mississippi.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: yesMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “MS” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Mississippi.

Recall timeline

FDA terminated this recall 4 months after the firm started it.

1. Firm started the recall: Jul 26, 201612. FDA classified it Class II: Sep 27, 201623. Published in FDA’s Enforcement Report: Oct 5, 201634. FDA terminated the recall: Nov 18, 201642016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1548-2016 (July 26, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1548-2016 to see it in context.
  • Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA